CervoMed Inc. (CRVO)
NASDAQ: CRVO · Real-Time Price · USD
3.980
-0.010 (-0.25%)
At close: Apr 17, 2026, 4:00 PM EDT
3.990
+0.010 (0.25%)
After-hours: Apr 17, 2026, 5:22 PM EDT
CervoMed Market Cap
CervoMed has a market cap or net worth of $36.85 million as of April 17, 2026. Its market cap has decreased by -68.82% in one year.
Market Cap
36.85M
Enterprise Value
15.99M
1-Year Change
-68.82%
Ranking
Category
Stock Price
$3.98
Market Cap Chart
Since August 17, 2023, CervoMed's market cap has decreased from $43.26M to $36.85M, a decrease of -14.82%. That is a compound annual growth rate of -5.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 36.85M | -49.59% |
| Dec 31, 2025 | 73.10M | 278.47% |
| Dec 31, 2024 | 19.31M | -55.39% |
| Dec 29, 2023 | 43.30M | 0.08% |
| Aug 17, 2023 | 43.26M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Actinium Pharmaceuticals | 40.84M |
| CEL-SCI | 38.68M |
| Passage Bio | 38.46M |
| Veru Inc. | 38.36M |
| Lixte Biotechnology Holdings | 38.34M |
| INmune Bio | 38.02M |
| NextCure | 37.66M |
| Pluri | 36.99M |